Twin Focus Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,883
Closed -$448K 203
2023
Q2
$448K Buy
3,883
+368
+10% +$41.8K 0.09% 119
2023
Q1
$374K Hold
3,515
0.07% 134
2022
Q4
$390K Sell
3,515
-12
-0.3% -$1.23K 0.08% 122
2022
Q3
$304K Buy
3,527
+99
+3% +$8.84K 0.07% 145
2022
Q2
$313K Buy
3,428
+112
+3% +$9.93K 0.07% 143
2022
Q1
$272K Buy
3,316
+131
+4% +$10.3K 0.05% 176
2021
Q4
$244K Buy
+3,185
New +$254K 0.05% 195
2021
Q3
Sell
-3,025
Closed -$235K 196
2021
Q2
$235K Buy
+3,025
New +$225K 0.05% 166
2019
Q4
Sell
-2,919
Closed -$234K 202
2019
Q3
$234K Buy
+2,919
New +$234K 0.09% 139
2014
Q1
Sell
-6,480
Closed -$309K 81
2013
Q4
$309K Buy
6,480
+1,027
+19% +$46.9K 0.3% 56
2013
Q3
$248K Buy
5,453
+378
+7% +$17.3K 0.24% 66
2013
Q2
$225K Buy
+5,075
New +$227K 0.23% 70

Other funds holding MRK

Twin Focus Capital Partners's MRK Position: Q3 2023 in Review

Twin Focus Capital Partners sold out of Merck (MRK) in Q3 2023, closing a stake of 3,883 shares — an estimated $448K sold.

Twin Focus Capital Partners first reported a position in MRK in Q2 2013 and held it in 12 quarters. The position peaked at $448K in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Twin Focus Capital Partners reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 3,883 Merck shares in Q3 2023, an estimated $448K.
  • Twin Focus Capital Partners first reported a position in Merck in Q2 2013 and held it in 12 quarters.
  • Twin Focus Capital Partners's Merck position peaked at $448K in Q2 2023.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.